CBUS

CIBUS INC

CBUS·17166A101·US·Common Stock·Healthcare - Biotechnology-Activist

CBUS (CIBUS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: FMR LLC ($22.6M), VANGUARD CAPITAL MANAGEMENT LLC ($4.2M), UNITED CAPITAL FINANCIAL ADVISORS, LLC ($1.1M). Net institutional sentiment: Bullish.

44
Holders
Avg rating(9 Elite)
$35.7M
Total Value
84% (48)
Fund Consensus
38 buying - 7 selling
CBUSSmart Money Verdict
View all
Held by 44 funds
9 elite
Who's Trading
ActivistFMR LLCFMR LLC15.0%May 6, 2026
InsiderBPBeetham PeterVest 195K shApr 24, 2026
InsiderGWGocal Gregory Francis WilliamVest 57K shApr 24, 2026
InsiderSJStokes JasonVest 57K shApr 24, 2026
InsiderBCBroos CarloVest 57K shApr 24, 2026
InsiderSNSauer NoelVest 38K shApr 24, 2026
ActivistARArmistice Capital, LLC5.0%Aug 14, 2025
InsiderSNSauer NoelSell $5.94Jun 13, 2025
ActivistRBRory B. Riggs33.0%Jun 10, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.4M(+56.1%)$22.6M0.0%-22.50%
40
New
2.1M$4.2M0.0%-42.78%
37
New
576,043$1.1M0.0%-42.78%
35
Increased
482,909(+75.5%)$956,4650.0%-73.37%
38
Increased
425,042(+246.2%)$841,5830.0%-30.77%
40
Increased
415,176(+32.5%)$822,0490.0%-26.67%
22
New
312,103$617,9640.0%-42.78%
34
Increased
263,858(+993.6%)$522,4390.0%-39.91%
39
New
258,148$511,1330.0%-42.78%
33
Increased
218,329(+316.9%)$432,2910.0%-35.71%
26
Increased
164,974(+97.8%)$326,6490.0%-22.30%
38
Increased
157,189(+108.0%)$311,2340.0%-68.03%
26
New
151,435$299,8410.0%-42.78%
32
New
105,293$208,4800.0%-42.78%
32
Increased
104,711(+84.0%)$207,3270.0%-64.83%
24
Increased
98,900(+42.5%)$195,8220.0%-3.16%
31
Increased
86,206(+97.4%)$170,6880.0%-22.25%
36
New
85,446$169,1830.0%-42.78%
31
Increased
74,358(+324.2%)$147,2280.0%-37.72%
25
Increased
56,221(+282.8%)$111,3180.0%-36.23%
24

Showing 1-20 of 48

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used